Oslo, Norway, 16 April 2021

Vistin Pharma ASA will release its first quarter 2021 results on Friday 23^rd of April 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 23^rd of April at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in Norwegian.

The first quarter conference call will be available via web and audio through the following access points:

Telephone conference:
Confirmation Code:........ 4598958
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.